should not be postponed if atypical pneumonia is suspected and the patient is not improving. The pharmacist should educate the patient on medication adherence and the importance of having the annual influenza vaccine among at-risk and older patients. Nurses should closely monitor patients for respiratory distress, nutrition, and mental status changes. For outpatient management, an infectious disease nurse should follow up with patients in a clinic to ensure proper recovery. If complications arise, the infectious disease physician should reassess the patient for appropriate management, with radiology involved in evaluating any related complications.[106] To minimize morbidity and mortality, it is essential to monitor patients until complete resolution of symptoms is achieved.[107] Close communication and coordination among the interprofessional team are vital for improving patient outcomes. ## Review Questions - [Access free multiple choice questions on this topic.](https://www.statpearls.com/account/trialuserreg/?articleid=27355&utm_source=pubmed&utm_campaign=reviews&utm_content=27355) - [Click here for a simplified version.](https://mdsearchlight.com/infectious-disease/atypical-bacterial-pneumonia/?utm_source=pubmedlink&utm_campaign=MDS&utm_content=27355) - [Comment on this article.](https://www.statpearls.com/articlelibrary/commentarticle/27355/?utm_source=pubmed&utm_campaign=comments&utm_content=27355) ## References 1. Miyashita N. Atypical pneumonia: Pathophysiology, diagnosis, and treatment. Respir Investig. 2022 Jan;60(1):56-67. \[[PubMed: 34750083](https://pubmed.ncbi.nlm.nih.gov/34750083)\] 2. Jain V, Vashisht R, Yilmaz G, Bhardwaj A. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 31, 2023. Pneumonia Pathology. \[[PubMed: 30252372](https://pubmed.ncbi.nlm.nih.gov/30252372)\] 3. Thibodeau KP, Viera AJ. Atypical pathogens and challenges in community-acquired pneumonia. Am Fam Physician. 2004 Apr 01;69(7):1699-706. \[[PubMed: 15086042](https://pubmed.ncbi.nlm.nih.gov/15086042)\] 4. Waites KB, Ratliff A, Crabb DM, Xiao L, Qin X, Selvarangan R, Tang YW, Zheng X, Dien Bard J, Hong T, Prichard M, Brooks E, Dallas S, Duffy L, Mixon E, Fowler KB, Atkinson TP. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program. J Clin Microbiol. 2019 Nov;57(11) \[[PMC free article: PMC6813023](/pmc/articles/PMC6813023/)\] \[[PubMed: 31484701](https://pubmed.ncbi.nlm.nih.gov/31484701)\] 5. Marston BJ, Plouffe JF, File TM, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997 Aug 11-25;157(15):1709-18. \[[PubMed: 9250232](https://pubmed.ncbi.nlm.nih.gov/9250232)\] 6. Xu D, Li S, Chen Z, Du L. Detection of Mycoplasma pneumoniae in different respiratory specimens. Eur J Pediatr. 2011 Jul;170(7):851-8. \[[PubMed: 21107602](https://pubmed.ncbi.nlm.nih.gov/21107602)\] 7. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA., Community-Acquired Pneumonia Organization (CAPO) Investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086-93. \[[PubMed: 17332485](https://pubmed.ncbi.nlm.nih.gov/17332485)\] 8. Jain S, Williams DJ, Arnold SR,